Lichen Health, Growing in symbiosis
Consulting firm in the management of innovation in healthcare.
Lichen Health, cornerstone among Deeptech and Digital Health Startups, Hospitals, Pharma Corporates and Investors.
Customized innovative services to address the challenges of disruptive project development in healthcare.
Lichen Health provides suited expertise as well as a tailored guidance that allow each project to grow up in symbiosis with its ecosystem.
Because health is everyone’s most precious asset and each project is unique.
Define
the target market
Helps you figure out the insights and the needs of the various players in the complex health ecosystem.
Testing the viability and robustness of the Business Model
Brings a fresh perspective, challenges the CEO's business plan.
Developing strategic collaborations
Relies on its network of KOLs, hospital and academic experts, pharmaceutical industry decision-makers and investors.
Strengthening the scientific value of the solution
Offers a comprehensive technico-medical evaluation of the project.
Operational support to the CEO
Provides a day-to-day operational support to the CEO of start-up to develop its innovation project.
An approach aligned with the values of our customers.
Lichen Health works with several health stakeholders: Entrepreneurs, Doctors, Researchers, Biopharmaceutical Corporates, Investors and Startups’ Incubators or Accelerators.
Because we share the conviction that each project is first and foremost a human history that requires singular attention and a mobilization of all the expertise along the way, from inception to success.
Lichen Health brings you its expertise throughout appropriate coaching or mentoring program.
Lichen Health brings you its knowledge and expertise to foster digital health startups’ development.
Lichen Health supports you in your digital transformation process.
Lichen Health is here to help you grow in symbiosis with your ecosystem.
Marie-Pierre Chevalier
About us
Your consultant, Marie-Pierre Chevalier is a physician by training with more than 20 years of experience in major biopharmaceutical groups including 10 years in the fields of open innovation and research partnerships.
Previously, Strategic Alliances Director, Pfizer France.
